New Age Alpha Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
New Age Alpha Advisors, LLC
- $2.27 Trillion
- Q2 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 117,597 shares of BMRN stock, worth $6.68 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
117,597
Previous 104,777
12.24%
Holding current value
$6.68 Million
Previous $7.41 Billion
12.72%
% of portfolio
0.28%
Previous 0.33%
Shares
3 transactions
Others Institutions Holding BMRN
# of Institutions
670Shares Held
185MCall Options Held
1.22MPut Options Held
962K-
Black Rock Inc. New York, NY22.7MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$896 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$849 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$613 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...